Lucia Care ApS
Private limited companyCVR 42499781Odense CActive
Lucia Care ApS is a private limited company, based in Odense C, active in manufacture of pharmaceutical preparations, founded in 2021. Equity was negative at the end of 2025 (−DKK 6.8m). The company made a loss in both 2024 and 2025, most recently DKK 2.2m.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss grew: from DKK 1.5m to DKK 2.2m (2024 → 2025).
Management and owners, last 24 months
- Stepped down: Mikkel Egelund Jensen (board member, 22/09/2025).
Registrations, last 24 months
- 06/10/2026: Moved to Albani Torv 4, 5000 Odense C
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2021–2025 · amounts in DKK thousandEquity and net profit
| 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | −595 | −930 | −912 | −591 | −621 | −5% |
| Operating profit (EBIT) | – | – | – | −1,501 | −2,133 | −42.1% |
| Net profit | −841 | −1,704 | −2,229 | −1,505 | −2,175 | −44.5% |
| Total assets | 1,449 | 917 | 1,562 | 1,429 | 1,206 | −15.6% |
| Equity | 970 | −940 | −3,169 | −4,674 | −6,849 | −46.5% |
| Liabilities | 478 | 1,857 | 4,731 | 6,103 | 8,055 | +32% |
| Cash and cash equivalents | 98 | 88 | 69 | 53 | 62 | +18% |
| Average number of employees | 1 | 2 | 4 | 3 | 3 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresNegative equity
Equity was −DKK 6.8m at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 5 years in a row
Net result has been negative in 2021–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
5 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 10/07/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 01/07/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 06/07/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 15/07/2023 | The company | PDFXBRL |
| 2021 | 29/06/2021 – 31/12/2021 | 22/07/2022 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
59 companies in the databaseComparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.
Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 68,326of 69,742 Better than 2% | No. 69,389of 69,964 Better than 1% |
| Same industry and fewer than 20 employees37 companies in the comparison | No. 21of 36 Better than 43% | No. 32of 37 Better than 14% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 32,981of 33,588 Better than 2% | No. 33,217of 33,687 Better than 1% |
| All companies of type ApS66,508 companies in the comparison | No. 65,285of 66,379 Better than 2% | No. 65,930of 66,505 Better than 1% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of pharmaceutical preparations- Lucia Care ApS−DKK 621k
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Lucia Care ApS−DKK 2.2m
- Novo Nordisk A/SDKK 102.4bn
- H. Lundbeck A/SDKK 3.2bn
- Lucia Care ApS−DKK 6.8m
- Novo Nordisk A/SDKK 194bn
- H. Lundbeck A/SDKK 24.9bn
- Lucia Care ApS4
- Novo Nordisk A/S27,279
- H. Lundbeck A/S2,261
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Derma Pharm A/S10%
- Lucia-Holding ApS90%
Management
5 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Nanna Rebecca Kirkebjerg | Director | 29/06/2021 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Nanna Rebecca Kirkebjerg | Board member | 29/06/2021 |
| Christian Gerhard Bøving | Board member | 29/06/2021 |
| Anne Stampe Olesen | Board member | 29/06/2021 |
| Søren Bjørrild Bregendal | Board member | 04/09/2024 |
- Founders
- Lucia-Holding ApS
Former management (2)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Mia Therese Wagner | Board member | 29/06/2021 | 23/11/2023 |
| Mikkel Egelund Jensen | Board member | 29/06/2021 | 22/09/2025 |
Signing rule: Selskabet tegnes af direktøren.
Address and production units
1 active production unitsAlbani Torv 4
5000 Odense C
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Lucia Care ApS | Albani Torv 4, 5000 Odense C | 4 | 1027302439 |
Purpose
Selskabets formål er at drive virksomhed med produktion af økologiske, bæredygtige og lægeudviklede hudprodukter indeholdende lægeurter, med fokus på integrativ medicin og sundhed, samt enhver virksomhed i hermed stående forbindelse.
The purpose is quoted from the register in Danish.
Changes year by year
18 registered events20262 changesaddress 1 · accounts 1
- AddressMoved to Albani Torv 4, 5000 Odense C
- AccountsAnnual report for 2025 published
20252 changesmanagement 1 · accounts 1
- ManagementMikkel Egelund Jensen stepped down as board member
- AccountsAnnual report for 2024 published
20242 changesmanagement 1 · accounts 1
- ManagementSøren Bjørrild Bregendal appointed board member
- AccountsAnnual report for 2023 published
20232 changesmanagement 1 · accounts 1
- ManagementMia Therese Wagner stepped down as board member
- AccountsAnnual report for 2022 published
20221 changeaccounts 1
- AccountsAnnual report for 2021 published
20219 changesfounded 1 · management 6 · ownership 2
- FoundedRegistered as Lucia Care ApS
- ManagementMikkel Egelund Jensen appointed board member
- ManagementNanna Rebecca Kirkebjerg appointed director
- ManagementMia Therese Wagner appointed board member
- ManagementChristian Gerhard Bøving appointed board member
- ManagementAnne Stampe Olesen appointed board member
- ManagementNanna Rebecca Kirkebjerg appointed board member
- OwnershipDERMA PHARM A/S registered as owner (10%)
- OwnershipLucia-Holding ApS registered as owner (90%)
Related companies
Same people in management
- Derma Pharm A/Svia Mikkel Egelund Jensen
- Vinhuset ApSvia Anne Stampe Olesen
- Media Group Denmark ApSvia Anne Stampe Olesen
- Eyda ApSvia Anne Stampe Olesen
- DecoFarver ApSvia Mia Therese Wagner
- a4medier ApSvia Mia Therese Wagner
Largest in the industry
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Leo Pharma A/SDKK 8.2bn
- Alk-abelló A/SDKK 4.2bn
- Bavarian Nordic A/SDKK 3bn
- Pharmacosmos A/SDKK 1.6bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.